Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Uterine Tubes

Uterine Tubes

The uterine or fallopian tubes function as the conduit through which oocytes travel from the ovaries to the uterus. Each fallopian tube measures approximately 10 to 13 cm long and is anatomically divided into the infundibulum, ampulla, isthmus, and interstitial part (or intramural segment). The infundibulum is characterized by its funnel shape and features extensions called fimbriae which reach towards the peritoneal cavity. These fimbriae play a critical role during ovulation as they extend...

Uterus and Cervix

Uterus and Cervix

The uterus, commonly called the womb, is a vital reproductive organ in females designed to provide a nurturing environment for the implantation and growth of an embryo. It is shaped like a hollow pear and positioned between the urinary bladder and the rectum. The uterus's structure allows it to support and protect a developing fetus throughout pregnancy.
The uterus is securely anchored within the pelvic cavity by paired broad ligaments on either side. It is further stabilized by three pairs...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hemoglobin level associates with survival in women from Appalachian Kentucky with uterine cervix cancer.

Frontiers in oncology·2023

Same author

Addressing the Challenges of Aggressive Lymphomas.

Journal of the advanced practitioner in oncology·2021

Same author

Clinicopathological effects of body composition measurements for patients with endometrial cancer.

Minerva ginecologica·2020

Same author

Membrane associated collagen XIII promotes cancer metastasis and enhances anoikis resistance.

Breast cancer research : BCR·2018

Same author

Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life.

Oncology nursing forum·2006

Same author

Quality of life 5 or more years post-autologous hematopoietic stem cell transplant.

Cancer nursing·2005

Search research articles

Related Experiment Video

Updated: Oct 3, 2025

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

Uterine Leiomyosarcoma.

Katherine L Byar¹, Tricia Fredericks²

¹Nebraska Medicine, Omaha, Nebraska.

Journal of the Advanced Practitioner in Oncology

|February 17, 2022

Summary

Uterine leiomyosarcoma (uLMS) is a rare uterine cancer with poor prognosis. This case study reviews current and emerging therapies for advanced or recurrent uLMS.

Area of Science:

Gynecologic Oncology
Sarcoma Research
Medical Therapeutics

Background:

Uterine leiomyosarcoma (uLMS) is the most common uterine malignancy, accounting for 2-5% of all uterine cancers.
Despite being diagnosed in early stages for most patients (60%), uLMS has a poor prognosis due to treatment resistance.
Surgical resection is standard for localized disease, but adjuvant chemotherapy benefits remain controversial for early-stage uLMS.

Purpose of the Study:

To review current therapeutic strategies for uterine leiomyosarcoma.
To highlight emerging novel therapies for advanced and recurrent uLMS.
To provide insights into managing this aggressive gynecologic cancer.

Main Methods:

Literature review of current and emerging treatments for uLMS.

More Related Videos

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

Related Experiment Videos

Last Updated: Oct 3, 2025

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

Analysis of clinical trial data for advanced and recurrent disease.

Case study approach to illustrate therapeutic challenges and advancements.

Main Results:

Surgical resection remains the primary treatment for localized uLMS.
Adjuvant chemotherapy efficacy for early-stage uLMS is not definitively established.
Significant progress is being made in developing novel therapies for advanced and recurrent uLMS.

Conclusions:

Uterine leiomyosarcoma presents a significant therapeutic challenge due to its aggressive nature and resistance to standard treatments.
While localized disease is managed with surgery, options for advanced or recurrent uLMS are evolving.
Emerging data on novel therapies offers hope for improved outcomes in women with advanced or recurrent uterine leiomyosarcoma.